Evidence for Cross-Protection but Not Type-Replacement Over the 11 Years After Human Papillomavirus Vaccine Introduction
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1564438
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2019
Authors
Publisher
Informa UK Limited